JoVE Logo

サインイン

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.

In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative deamination can occur, resulting in the formation of simpler amines, such as amphetamine.

Additional transformations can also occur, such as N-oxide formation in basic nitrogen atoms and N-hydroxylation in non-basic nitrogen atoms or those lacking an α-hydrogen.

Carbon-sulfur systems can undergo processes like S-dealkylation, S-alkylation, desulphurization, and S-oxidation. Sulphonamides and thiols, commonly found in various drugs, typically undergo these reactions. In contrast, carbon-oxygen systems predominantly undergo O-dealkylation. A classic example of a drug undergoing this type of reaction is codeine.

In addition to these specific reactions, there are also miscellaneous oxidative reactions. For example, reductive dehalogenation can occur in fluorocarbons like halothane, and the reduction of sulfur-containing groups can be seen in drugs like disulfiram. Understanding these complex biochemical reactions is critical in the pharmaceutical industry. Researchers and healthcare professionals can design and administer safer and more effective therapies by understanding how different compounds interact with the body's metabolic processes.

タグ

Phase I ReactionsOxidative ReactionsCarbon heteroatom SystemsCarbon nitrogen SystemsAliphatic AminesN dealkylationOxidative DeaminationCarbon sulfur SystemsS oxidationSulphonamidesO dealkylationCodeineMiscellaneous Oxidative ReactionsReductive DehalogenationPharmaceutical Industry

章から 5:

article

Now Playing

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

69 閲覧数

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

403 閲覧数

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

246 閲覧数

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

153 閲覧数

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

185 閲覧数

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

82 閲覧数

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

172 閲覧数

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

314 閲覧数

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

186 閲覧数

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

158 閲覧数

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

195 閲覧数

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

156 閲覧数

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

48 閲覧数

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

199 閲覧数

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

125 閲覧数

JoVE Logo

個人情報保護方針

利用規約

一般データ保護規則

研究

教育

JoVEについて

Copyright © 2023 MyJoVE Corporation. All rights reserved